243 related articles for article (PubMed ID: 30290124)
61. Cooperation of immune regulators Tollip and surfactant protein A inhibits influenza A virus infection in mice.
Schaunaman N; Cervantes D; Nichols T; Numata M; Ledford JG; Kraft M; Chu HW
Respir Res; 2024 May; 25(1):193. PubMed ID: 38702733
[TBL] [Abstract][Full Text] [Related]
62. Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection.
Shi Y; Xu H; Xiao Y; Liu P; Pang P; Wu S; Deng L; Chen X
Biomed Pharmacother; 2020 Jan; 121():109471. PubMed ID: 31707346
[TBL] [Abstract][Full Text] [Related]
63. Diversity of locally produced IFN-α subtypes in human nasopharyngeal epithelial cells and mouse lung tissues during influenza virus infection.
Yang L; Wang S; Wang Y; Zhao P; Cui C; Tu L; Li X; Yu Y; Li H; Wang L
Appl Microbiol Biotechnol; 2020 Jul; 104(14):6351-6361. PubMed ID: 32472176
[TBL] [Abstract][Full Text] [Related]
64. SNW1 interacts with IKKγ to positively regulate antiviral innate immune responses against influenza A virus infection.
Zhang Q; Liang T; Gu S; Ye Y; Liu S
Microbes Infect; 2020; 22(10):576-584. PubMed ID: 32805409
[TBL] [Abstract][Full Text] [Related]
65. Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1.
Zhan Z; Cao H; Xie X; Yang L; Zhang P; Chen Y; Fan H; Liu Z; Liu X
J Immunol; 2015 Oct; 195(8):3849-57. PubMed ID: 26363053
[TBL] [Abstract][Full Text] [Related]
66. PM2.5 compromises antiviral immunity in influenza infection by inhibiting activation of NLRP3 inflammasome and expression of interferon-β.
Tao RJ; Cao WJ; Li MH; Yang L; Dai RX; Luo XL; Liu Y; Ge BX; Su X; Xu JF
Mol Immunol; 2020 Sep; 125():178-186. PubMed ID: 32717666
[TBL] [Abstract][Full Text] [Related]
67. Impaired clearance of influenza A virus in obese, leptin receptor deficient mice is independent of leptin signaling in the lung epithelium and macrophages.
Radigan KA; Morales-Nebreda L; Soberanes S; Nicholson T; Nigdelioglu R; Cho T; Chi M; Hamanaka RB; Misharin AV; Perlman H; Budinger GR; Mutlu GM
PLoS One; 2014; 9(9):e108138. PubMed ID: 25232724
[TBL] [Abstract][Full Text] [Related]
68. Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus.
Tate MD; Schilter HC; Brooks AG; Reading PC
Viral Immunol; 2011 Apr; 24(2):77-88. PubMed ID: 21449718
[TBL] [Abstract][Full Text] [Related]
69. Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation.
Verma V; Dileepan M; Huang Q; Phan T; Hu WS; Ly H; Liang Y
PLoS Pathog; 2022 Sep; 18(9):e1010874. PubMed ID: 36121891
[TBL] [Abstract][Full Text] [Related]
70. Infection with influenza virus induces IL-33 in murine lungs.
Le Goffic R; Arshad MI; Rauch M; L'Helgoualc'h A; Delmas B; Piquet-Pellorce C; Samson M
Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1125-32. PubMed ID: 21642589
[TBL] [Abstract][Full Text] [Related]
71. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
Front Immunol; 2018; 9():2589. PubMed ID: 30473701
[TBL] [Abstract][Full Text] [Related]
72. Leukotriene B4 Enhances NOD2-Dependent Innate Response against Influenza Virus Infection.
Le Bel M; Gosselin J
PLoS One; 2015; 10(10):e0139856. PubMed ID: 26444420
[TBL] [Abstract][Full Text] [Related]
73. Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection.
Cao W; Taylor AK; Biber RE; Davis WG; Kim JH; Reber AJ; Chirkova T; De La Cruz JA; Pandey A; Ranjan P; Katz JM; Gangappa S; Sambhara S
J Immunol; 2012 Sep; 189(5):2257-65. PubMed ID: 22855715
[TBL] [Abstract][Full Text] [Related]
74. The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus.
Kim HM; Kang YM; Ku KB; Park EH; Yum J; Kim JC; Jin SY; Lee JS; Kim HS; Seo SH
Virology; 2013 Sep; 444(1-2):394-403. PubMed ID: 23890814
[TBL] [Abstract][Full Text] [Related]
75. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
76. Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.
Tatsumi K; Schmedes CM; Houston ER; Butler E; Mackman N; Antoniak S
Cell Immunol; 2019 Oct; 344():103949. PubMed ID: 31337508
[TBL] [Abstract][Full Text] [Related]
77. Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection.
Hatesuer B; Hoang HT; Riese P; Trittel S; Gerhauser I; Elbahesh H; Geffers R; Wilk E; Schughart K
J Innate Immun; 2017; 9(2):145-161. PubMed ID: 27811478
[TBL] [Abstract][Full Text] [Related]
78. DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation.
Kim SS; Lee KG; Chin CS; Ng SK; Pereira NA; Xu S; Lam KP
J Immunol; 2014 Jul; 193(2):840-8. PubMed ID: 24929003
[TBL] [Abstract][Full Text] [Related]
79. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways.
Allen IC; Moore CB; Schneider M; Lei Y; Davis BK; Scull MA; Gris D; Roney KE; Zimmermann AG; Bowzard JB; Ranjan P; Monroe KM; Pickles RJ; Sambhara S; Ting JP
Immunity; 2011 Jun; 34(6):854-65. PubMed ID: 21703540
[TBL] [Abstract][Full Text] [Related]
80. Cutting Edge: DNA in the Lung Microenvironment during Influenza Virus Infection Tempers Inflammation by Engaging the DNA Sensor AIM2.
Schattgen SA; Gao G; Kurt-Jones EA; Fitzgerald KA
J Immunol; 2016 Jan; 196(1):29-33. PubMed ID: 26590313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
